Divi's Laboratories Ltd

DIVISLAB

Company Profile

  • Business description

    Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.

  • Contact

    Cyber Hills
    Divi Towers, 1-72/23(P)/DIVIS/303
    Gachibowli
    HyderabadTG500032
    IND

    T: +91 4066966300

    https://www.divislabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    9,109

Stocks News & Analysis

stocks

Goodman earnings: All eyes on data center progress

Our view after results.
stocks

Earnings winners: BHP, NAB & TLS lead the pack

The winners of this weeks earnings that saw strong investor backing
stocks

Walmart earnings: Growth in digital buoys margin amid consumer trade-down

We think Walmart stock is significantly overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,303.209.300.10%
CAC 408,507.97109.191.30%
DAX 4025,260.69217.120.87%
Dow JONES (US)49,625.97230.810.47%
FTSE 10010,702.1075.060.71%
HKSE26,413.35292.59-1.10%
NASDAQ22,886.07203.340.90%
Nikkei 22556,825.70642.13-1.12%
NZX 50 Index13,308.52135.68-1.01%
S&P 5006,909.5147.620.69%
S&P/ASX 2009,081.4017.000.19%
SSE Composite Index4,082.0751.95-1.26%

Market Movers